These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30975715)

  • 21. The corporate co-author, the ghostwriter, and the medical society: an object lesson (June, 2005 issue).
    Goodman RL; Carrasquillo O
    J Gen Intern Med; 2006 Jan; 21(1):102. PubMed ID: 16423136
    [No Abstract]   [Full Text] [Related]  

  • 22. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Rev Port Cardiol; 2012 Apr; 31(4):329-36. PubMed ID: 22863109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cochrane's plans to update its COI policy: truth and fiction.
    Tovey D; Macbeth F; Webster A; Foxlee R
    Cochrane Database Syst Rev; 2018 Nov; 11(11):ED000131. PubMed ID: 30520518
    [No Abstract]   [Full Text] [Related]  

  • 25. Prioritization of Cochrane Systematic Reviews.
    Presley C; Rundle CW; Kolodziejczyk T; Andrews S; Shumaker P; Anand P; Lee K; Dellavalle RP; Boyle RJ
    Br J Dermatol; 2019 Dec; 181(6):1303-1304. PubMed ID: 31145811
    [No Abstract]   [Full Text] [Related]  

  • 26. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals].
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    G Ital Cardiol (Rome); 2012 Apr; 13(4):236-43. PubMed ID: 22495640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conflict of Interest and the CREATE-X Trial in the New England Journal of Medicine.
    Ozaki A
    Sci Eng Ethics; 2018 Dec; 24(6):1809-1811. PubMed ID: 28916944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Arq Bras Cardiol; 2012 Jun; 98(6):471-9. PubMed ID: 22892693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).
    Bruyere O; Kanis JA; Ibar-Abadie ME; Alsayed N; Brandi ML; Burlet N; Cahall DL; Chines A; Devogelaer JP; Dere W; Goel N; Hughes N; Kaufman JM; Korte S; Mitlak BH; Niese D; Rizzoli R; Rovati LC; Reginster JY
    Osteoporos Int; 2010 May; 21(5):713-22. PubMed ID: 20238101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
    Roper N; Korenstein D
    J Gen Intern Med; 2015 Oct; 30(10):1421-5. PubMed ID: 25832619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Circ J; 2012; 76(7):1542-9. PubMed ID: 22664980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Hellenic J Cardiol; 2012; 53(3):179-88. PubMed ID: 22653242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
    Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
    Heart; 2012 Apr; 98(7):e1-7. PubMed ID: 22422746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Are authors allowed to make up what is valid when it comes to challenge and conflict of interest?].
    Werkö L
    Lakartidningen; 2002 Sep; 99(36):3542; author reply 3542. PubMed ID: 12362759
    [No Abstract]   [Full Text] [Related]  

  • 36. Response to "the corporate coauthor".
    Wager E; Jacobs A
    J Gen Intern Med; 2005 Jul; 20(7):672. PubMed ID: 16050869
    [No Abstract]   [Full Text] [Related]  

  • 37. Five-step authorship framework to improve transparency in disclosing contributors to industry-sponsored clinical trial publications.
    Marušić A; Hren D; Mansi B; Lineberry N; Bhattacharya A; Garrity M; Clark J; Gesell T; Glasser S; Gonzalez J; Hustad C; Lannon MM; Mooney LA; Peña T
    BMC Med; 2014 Oct; 12():197. PubMed ID: 25604352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reflections on the Physicians Payment Sunshine Act.
    Frishman WH
    Am J Med; 2016 Jan; 129(1):3-4. PubMed ID: 26291906
    [No Abstract]   [Full Text] [Related]  

  • 39. Ghosts still present in the medical machine.
    Jones N
    Nature; 2009 Sep; 461(7262):325. PubMed ID: 19759590
    [No Abstract]   [Full Text] [Related]  

  • 40. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.